Arvinas (ARVN) Non Operating Income (2017 - 2026)
Arvinas (ARVN) recorded Non Operating Income of $5.5 million in Q2 2026, down 45.0% from $10 million a year earlier and down 12.7% from the prior quarter.
Arvinas (ARVN) Non Operating Income (2017 - 2026) Analysis & Trends
On a TTM basis, Arvinas' Non Operating Income came in at $28.2 million as of Jun 30, 2026, down 38.8% year-over-year; for FY2025, it came in at $38 million, down 26.8% from FY2024.
- Annual Non Operating Income has a five-year compound annual growth rate of 46.7% (FY2020 to FY2025).
- Across earlier years, Non Operating Income came in at $51.9 million in FY2024 (+38.0%), $37.6 million in FY2023 (+208.2%), $12.2 million in FY2022 (+183.7%) and $4.3 million in FY2021 (-23.2%).
- The Q2 2026 figure is the lowest quarterly Non Operating Income since Q3 2022.
- On a year-over-year basis, Non Operating Income has declined for six consecutive quarters, with an average decline of 22.0% over the last eight quarters.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 540.0% in Q3 2022, against a decline of 46.2% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $6.3 million (Q1 2026), $7.4 million (Q4 2025) and $9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arvinas | 505.42 Mn | -2.15 Bn | - | 5.50 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.50 Mn |
| Mar 31, 2026 | 6.30 Mn |
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.70 Mn |
| Dec 31, 2024 | 12.70 Mn |
| Sep 30, 2024 | 11.70 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | 12.10 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 500,000.00 |
Arvinas Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARVN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ARVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ARVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();